Skip to main content

Table 2 Distribution of cases according to Age, USG score, menopausal status, serum CA 125 levels and RMI

From: A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass

Parameter Benign Malignant p-value
Age
  ≤ 20 5 (3.97%) 2 (1.59%)  
 20–39 26 (20.63%) 11 (8.7%)  
 40–59 21 (16.7%) 48 (38.1%)  
  ≥ 60 5 (3.97%) 08 (6.35%)  
Menstrual status
 Premenopausal 48 (62.34%) 29 (37.66%) 0.000
 Postmenopausal 9 (18.4%) 40 (81.6%) 0.000
USG characteristics
 Bilateral 16 (45.72%) 19 (54.28%) 0.947
 Multilocular 29 (46.03%) 34 (53.97%) 0.859
 Presence of solid areas 20 (24.69%) 61 (75.30%) 0.000
 Presence of ascites 9 (18.75%) 39 (81.25%) 0.000
 Presence of metastasis 1 (5.5%) 17 (94.4%) 0.000
USG SCORE
 1 35 (61.4%) 22 (38.6%) 0.001
 3 22 (31.88%) 47 (61.12%)  
SerumCA-125(U/ml) (Mean ± Sd) 69.89 ± 44.10 502.09 ± 1525.09 0.001
RMI (Mean ± Sd) 109.06 ± 47.49 3534.57 ± 13,653.83 0.013
RMI ≥ 236 1 (1.75%) 56 (98.24%) 0.000
RMI <236 56 (74.66%) 19 (25.34)